When was Vgenomics founded?

Vgenomics was founded in 2021 and raised its 1st funding round 3 years after it was founded.

Where is Vgenomics located?

Vgenomics is headquartered in Noida, India. It is registered at Flat no. 156C, LIG PKT-12, Jasola, South Delhi, Delhi, Delhi, India, 110025.

Which legal entities is Vgenomics associated with?

Vgenomics is associated with VGENOMICS INDIA PRIVATE LIMITED.

How many employees does Vgenomics have?

As of Sep 30, 2026, the latest employee count at Vgenomics is 15.

Is Vgenomics a funded company?

Vgenomics is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 16, 2024.

How much is Vgenomics worth?

The latest valuation of Vgenomics is ₹***** as of Dec 18, 2023. This marks a decline of 5% from its peak valuation of ₹37.5Cr in Sep, 2023. This marks a decline of 5% from its peak valuation of ₹37.5Cr in Sep, 2023.

When was the latest funding round of Vgenomics?

Vgenomics' latest funding was a $***** Seed round on Jan 16, 2024, with participation from 4 investors. Its primary sector is Genomics. In India, the Genomics sector has seen $26.5M in funding in 2026 to date.

What is the annual revenue of Vgenomics?

Annual revenue of Vgenomics is less than ₹10 Cr as on Mar 31, 2025

Where does Vgenomics rank among its competitors?

Vgenomics ranks 62nd amongst 613 active competitors, of which 65 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellanome, which secured $75.9M in Dec, 2025.

Who are the top competitors of Vgenomics?

Vgenomics' top competitors include BGI, Novogene Corporation and Hexagon Bio. Among them, Cellanome secured the most recent funding round in December, 2025.

Vgenomics - 2026 Company Profile, Team, Funding, Competitors & Financials

Vgenomics is a seed company based in Noida (India), founded in 2021 by Rahila Sardar and Preeti Gupta Lal. It operates as a Developer of diagnostic and therapeutic solutions for inborn diseases. Vgenomics has raised an undisclosed amount in funding from Mumbai Angels and O2 Angels Network, with a current valuation of ₹*****. The company has 613 active competitors, including 65 funded and 62 that have exited. Its top competitors include companies like BGI, Novogene Corporation and Hexagon Bio.

Company Details

Developer of diagnostic and therapeutic solutions for inborn diseases. It offers a comprehensive blood test and therapeutic solutions for rare inborn diseases. It also offer precise whole exome sequencing, RNAseq, and bioinformatics analysis services.

Website: vgenomics.in
Social
Email ID: *****@vgenomics.co.in
Phone Number: +91 **********
Registered Address: Flat no. 156C, LIG PKT-12, Jasola, South Delhi, Delhi, Delhi, India, 110025

Key Metrics

Founded Year

2021

Location

Noida, India

Stage

Seed

Latest Funding Round

Seed, Jan 16, 2024, $*****

Post Money Valuation

₹***** as on Dec 18, 2023

Investors

Mumbai Angels & 4 more

Ranked

62^nd among 613 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

15 as on Sep 30, 2026

Similar Companies

Novogene Corporation & 339 more

View Vgenomics' full profile

Vgenomics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
VGENOMICS INDIA PRIVATE LIMITED CIN: U85300DL2022PTC397081 , India, Active	Apr 21, 2022	0 - ₹10 Cr (As on Mar 31, 2025)	-

Vgenomics has raised funding over 1 round. Its latest funding round was a Seed round on Jan 16, 2024 for $*****. 4 investors participated in its latest round. Vgenomics has 3 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Vgenomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 16, 2024	2813942	Seed	1617280	5723403	1224545	1160277

Access funding benchmarks and valuations. Sign up today!

View details of Vgenomics's funding rounds and investors

The founders of Vgenomics are Rahila Sardar and Preeti Gupta Lal. Rahila Sardar is the CEO of Vgenomics.

Here are the details of Vgenomics' key team members:

Rahila Sardar: Co-Founder & CEO of Vgenomics. They serve on the board of 1 company.
Contact Info: 1 email address
Preeti Gupta Lal: Co-Founder & CSO of Vgenomics. They serve on the board of 1 company.
Contact Info: 1 email address

Vgenomics' Board of Directors

Vgenomics's board has 2 active members. Rahila Sardar and Preeti Gupta Lal are part of team.

Here is the list of Vgenomics' board of directors:

Name	Type	Representing	Status	Duration
Rahila Sardar	Team	-	Current	4y 6m
Preeti Gupta Lal	Team	-	Current	4y 2m

View details of Vgenomics's Founder profiles and Board Members

Vgenomics' employee count trend

Vgenomics has 15 employees as of Sep 26. Here is Vgenomics's employee count trend over the years:

Uncover Vgenomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vgenomics include BGI, Novogene Corporation and Hexagon Bio. Here is the list of Top 10 competitors of Vgenomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	66/100
2nd	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	64/100
3rd	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Two Sigma Ventures & 10 others	64/100
4th	Macrogen 1997, Seoul (South Korea), Public	Provider of a platform for next-generation sequencing	-	Atinum Investment, Aju IB Investment & 1 others	60/100
5th	Tessera Therapeutics 2017, Cambridge (United States), Series C	Provider of new genome engineering technology for treating multiple diseases	$610M	T. Rowe Price, ADIA & 22 others	59/100
6th	Cellanome 2020, Palo Alto (United States), Series B	Developer of the omic data platform for researchers	$119M	DFJ Growth, Premji Invest & 5 others	59/100
7th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	Perceptive Advisors, Domain Associates & 5 others	58/100
8th	Intus Bio 2014, Farmington (United States), Seed	Developer of sequencing technology for microbiome testing, pathogen identification, and tracking	$4.14M	Design Technologies, Connecticut Innovations ... & 4 others	56/100
9th	Replay 2021, San Diego (United States), Acquired	Provider of genomic reprogramming platform for writing and delivering big DNA	$55M	OMX Ventures, KKR & 6 others	55/100
10th	Navigene 2012, Mumbai (India), Seed	Provider of diagnosing genetic medical conditions and recommending preventive care	$838K	SAVA group, Ecosystem Ventures & 30 others	53/100
62nd	Vgenomics 2021, Noida (India), Seed	Developer of diagnostic and therapeutic solutions for inborn diseases	-	Mumbai Angels, O2 Angels Network & 3 others	37/100